BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
BiohacksAI/Compounds/Kml29
✓ FULLY PROFILED

Kml29

6+ PubMed studies analyzed · BiohacksAI corpus v20260307-01

Kml29 2D molecular structure
PubMed Studies
6+
Targets
2
Pathways
2
Molecular Targets
MGLLMONOGLYCERIDE

Molecular targets identified in BiohacksAI corpus. Click to explore all compounds affecting each target.

Biological Pathways
INFLAMMATIONNEUROTROPHIC

Biological pathways associated with Kml29 based on target analysis.

Biological Mechanisms
NF-κBNF-κBBDNFBDNF

Biological mechanisms activated or modulated by Kml29 based on pathway and target analysis.

Health Goals
Inflammation →Longevity →Memory →Neuroprotection →

Health goals where Kml29 ranks among evidence-based compounds in the BiohacksAI corpus.

Related Conditions
Chronic Inflammation →Arthritis →Alzheimer's →Depression →

Health conditions associated with the biological pathways influenced by Kml29.

External References
PubChem CID 71656212 →6 PubMed studies →
Similar Compounds

Explore compounds with similar target profiles and pathway overlap.

Find similar compounds to Kml29 →
Data Source
Corpusv20260307-01
PubMed studies6
PubChem CID71656212
SourcePubMed / NCBI · ChEMBL · Reactome · PubChem

All data is computationally derived from published research. Molecular structure images from PubChem (public domain). Not medical advice. Independent validation required.

This compound profile for Kml29 is generated from 6 PubMed-indexed studies. Key molecular targets include MGLL, MONOGLYCERIDE. Associated biological pathways: INFLAMMATION, NEUROTROPHIC. BiohacksAI does not provide medical advice. Consult a healthcare professional before starting any supplement regimen.